• Fiscal Year end for Oramed Pharmaceuticals Inc falls in the month of December .

    All items in Millions except EPS data.

    12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Sales 1 3 1 3 3
    Cost Of Goods 0 0 0 0 0
    Gross Profit 1 3 1 3 3
    Selling & Adminstrative & Depr. & Amort Expenses 17 43 13 27 14
    Income After Depreciation & Amortization -16 -41 -12 -24 -12
    Non-Operating Income 23 4 0 1 1
    Interest Expense 2 1 0 0 0
    Pretax Income 5 -38 -12 -23 -12
    Income Taxes 0 0 0 0 0
    Minority Interest 0 -1 -1 -1 0
    Investment Gains/Losses 0 0 0 0 0
    Other Income/Charges 0 0 0 0 0
    Income From Cont. Operations 5 -38 -12 -23 -12
    Extras & Discontinued Operations 0 0 0 0 0
    Net Income (GAAP) 6 -37 -12 -22 -12
    Depreciation Footnote 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Income Before Depreciation & Amortization -16 -41 -12 -24 -12
    Depreciation & Amortization (Cash Flow) 0 0 0 0 0
    Income After Depreciation & Amortization -16 -41 -12 -24 -12
    Earnings Per Share Data 12/31/23 12/31/22 12/31/21 12/31/20 12/31/19
    Average Shares 40.57 39.00 28.47 20.53 17.46
    Diluted EPS Before Non-Recurring Items -0.27 -0.94 -0.78 -0.56 0.82
    Diluted Net EPS (GAAP) 0.14 -0.94 -0.78 -0.78 -0.56

    Fiscal Year end for Oramed Pharmaceuticals Inc falls in the month of December .

    All items in Millions except EPS data.

    3/31/24 12/31/23 9/30/23 6/30/23 3/31/23
    Sales NA 0.00 0.00 0.67 0.67
    Cost Of Goods NA 0.00 0.00 0.00 0.00
    Gross Profit NA 0.00 0.00 0.67 0.67
    SG&A, R&D, and Dept/Amort Expenses 0.00 3.88 2.90 4.46 5.88
    Income After SG&A, R&D, and Dept/Amort Expenses 0.00 -3.88 -2.90 -3.79 -5.21
    Non-Operating Income NA 18.38 0.44 2.48 1.60
    Interest Expense NA 1.21 0.83 0.00 0.00
    Pretax Income NA 13.30 -3.28 -1.31 -3.61
    Income Taxes NA 0.00 0.00 0.00 0.00
    Minority Interest NA -0.26 -0.06 -0.12 0.00
    Investment Gains/Losses NA 0.00 0.00 0.00 0.00
    Other Income/Charges NA 0.00 0.00 0.00 0.00
    Income From Cont. Operations NA 13.30 -3.28 -1.31 -3.61
    Extras & Discontinued Operations NA 0.00 0.00 0.00 0.00
    Income (GAAP) NA 13.55 -3.22 -1.19 -3.61
    Earnings Per Share Data 3/31/24 12/31/23 9/30/23 6/30/23 3/31/23
    Average Shares NA 40.41 40.45 40.23 40.04
    Diluted EPS Before Non-Recurring Items NA -0.08 -0.08 -0.03 -0.08
    Diluted Net EPS (GAAP) NA 0.33 -0.08 -0.03 -0.08